Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
Clinical trial NCT00116961 · COMPLETED
Trial details
- NCT number
- NCT00116961
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2007-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.